GlassScriptPhysician profile
Hayley E Griffin
NPI 1699227538
$2,247.89
in general payments reported to CMS, 2019-2025
17 companies · $885 in 2025
The $885 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.96 · 2022: $140 · 2023: $629 · 2024: $561 · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,218.41 | 2022-2025 | |
| Galderma Laboratories, L.P. | $346.39 | 2023-2025 | Nemluvio, Dysport |
| Merz North America, INC. | $182.22 | 2023-2025 | Xeomin |
| Leo Pharma INC. | $79.91 | 2025 | Adbry, Anzupgo |
| Revance Therapeutics, INC. | $75.49 | 2024 | Daxxify |
| Lilly USA, LLC | $61.69 | 2025 | Taltz, Ebglyss |
| Allergan, INC. | $46.76 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $33.19 | 2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $28.30 | 2024 | Xarelto |
| Ucb, INC. | $27.94 | 2025 | Bimzelx |
| Organon LLC | $27.12 | 2025 | |
| Globus Medical, INC. | $25.75 | 2025 | Mars |
| Mimedx Group, INC. | $21.11 | 2025 | |
| Amgen INC. | $20.35 | 2025 | Otezla |
| Irhythm Technologies, INC. | $19.42 | 2024 | Zio Xt Patch |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.31 | 2023 | |
| Sun Pharmaceutical Industries INC. | $15.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayley Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.